 |
 |
Yes, the list still exists. On Tue, Mar 5, 2019 at 1:00 AM jc u <[log in to unmask]> wrote: > Hello, > > Does this list still exist? If not, is there an alternate list or social > media platform? > > Thank you for your reply. > > > > > > > On Jul 12, 2018, at 1:28 PM, Rayilyn Brown <[log in to unmask]> wrote: > > > > Parkinson's News Today Daily Digest > > > > From: Parkinson's News Today > > Sent: Thursday, July 12, 2018 8:04 AM > > To: =?utf-8?Q??= > > Subject: Parkinson's News Today Daily Digest > > > > See below for a daily digest of the latest Parkinson's > Disease news & perspectives! Is this email not displaying correctly? > > View it in your browser. > > > > > > > > Parkinson's News Today Daily Digest > > Contents: > > > > a.. More Than 1 Million Cases of Parkinson’s > Predicted in the US by 2030, Study Reports > > b.. Mirapex Sustained Release Tablet > Outperforms Immediate Release Version to Relieve Sleep Disturbances > > > > More Than 1 Million Cases of Parkinson’s > Predicted in the US by 2030, Study Reports > > Jul 12, 2018 07:00 am | Alice Melão > > > > Approximately 1.2 million people in the > United States are predicted to have Parkinson’s disease by the year 2030, > according to the results of a large-scale study. This represents a > projected increase by about 1.8 times in Parkinson’s prevalence since 2010, > highlighting the need for optimized care and treatment strategies for this > patient population to diminish the burden […] > > > > The post More Than 1 Million Cases of > Parkinson’s Predicted in the US by 2030, Study Reports appeared first on > Parkinson's News Today. > > > > Read More > > > > > > Mirapex Sustained Release Tablet > Outperforms Immediate Release Version to Relieve Sleep Disturbances > > Jul 12, 2018 07:00 am | Jose Marques Lopes, > PhD > > > > Sustained release formulation of > pramipexole (Mirapex, Boehringer Ingelheim) outperforms its immediate > release alternative to treat sleep disturbances in advanced Parkinson’s > patients, a new study suggests. The research, “Comparison of nocturnal > symptoms in advanced Parkinson’s disease patients with sleep disturbances: > pramipexole sustained release versus immediate release formulations,” was > published in Drug Design, Development and Therapy. Sleep disturbances, > which may include […] > > > > The post Mirapex Sustained Release Tablet > Outperforms Immediate Release Version to Relieve Sleep Disturbances > appeared first on Parkinson's News Today. > > > > Read More > > > > > > > > > > > > Recent Posts > > ‘You Don’t Look Sick’ > > PBT434 Prevents Neuron Loss, Improves Motor > Function in Animal Model of Neurodegeneration, Prana Reports > > 3D Structure of Alpha-Synuclein Challenges > Previous Theory of Parkinson’s > > Herantis Announces New Program to Develop > Non-Invasive CDNF for Parkinson’s Treatment > > Where Does Your Strength Come From? > > > > > > > > > > > > > > Copyright © 2018 BioNews Services, LLC, All rights > reserved. > > You are receiving this email because you opted in at > our website http://parkinsonsnewstoday.com/ > > > > Our mailing address is: > > > > BioNews Services, LLC > > 5307 E. Mockingbird Ln. > > Fifth Floor > > Dallas, TX 75206 > > > > Add us to your address book > > unsubscribe from this list | update subscription > preferences > > > > > > > > > > ---------------------------------------------------------------------- > > To sign-off Parkinsn send a message to: mailto: > [log in to unmask] > > In the body of the message put: signoff parkinsn > > > > ---------------------------------------------------------------------- > To sign-off Parkinsn send a message to: mailto: > [log in to unmask] > In the body of the message put: signoff parkinsn > ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn